首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5004篇
  免费   356篇
  国内免费   57篇
耳鼻咽喉   36篇
儿科学   105篇
妇产科学   104篇
基础医学   671篇
口腔科学   40篇
临床医学   434篇
内科学   1126篇
皮肤病学   100篇
神经病学   464篇
特种医学   249篇
外科学   1073篇
综合类   33篇
一般理论   4篇
预防医学   220篇
眼科学   123篇
药学   276篇
中国医学   8篇
肿瘤学   351篇
  2022年   31篇
  2021年   87篇
  2020年   91篇
  2019年   122篇
  2018年   133篇
  2017年   86篇
  2016年   109篇
  2015年   136篇
  2014年   196篇
  2013年   232篇
  2012年   335篇
  2011年   329篇
  2010年   185篇
  2009年   174篇
  2008年   287篇
  2007年   262篇
  2006年   290篇
  2005年   272篇
  2004年   226篇
  2003年   250篇
  2002年   224篇
  2001年   102篇
  2000年   104篇
  1999年   92篇
  1998年   76篇
  1997年   57篇
  1996年   48篇
  1995年   44篇
  1994年   31篇
  1993年   28篇
  1992年   49篇
  1991年   57篇
  1990年   53篇
  1989年   62篇
  1988年   58篇
  1987年   52篇
  1986年   36篇
  1985年   28篇
  1984年   25篇
  1983年   37篇
  1982年   15篇
  1981年   24篇
  1980年   17篇
  1979年   20篇
  1978年   30篇
  1977年   22篇
  1976年   16篇
  1975年   27篇
  1973年   20篇
  1968年   17篇
排序方式: 共有5417条查询结果,搜索用时 31 毫秒
101.
102.
Background : We performed a retrospective analysis of the maze IV procedures performed in our surgical department for concomitant atrial fibrillation.

Methods : Preoperative, in-hospital and postoperative follow-up data were collected from 46 consecutive patients who underwent the maze IV operation between April 2006 and December 2010. All electrocardiograms and Holters were reviewed.

Results : One patient died in-hospital. During a mean follow-up of 25 ± 16.3 months seven patients died: two related to a hemorrhagic stroke, one due to right ventricular failure, the remainder deaths were not cardiac related. The success rate, defined as no recurrence of AF or atrial flutter with a blanking period of 6 months postoperatively, was 73.7%. Plots of probability of freedom of atrial fibrillation over time are drawn and reach a stable level after one year. Conclusions : The mid term results of the maze IV procedures for concomitant atrial fibrillation are very good. The results are stable for the remainder of follow-up.  相似文献   
103.
Ovarian cancer is associated with a leukocyte infiltrate and high levels of chemokines such as CCL2. We tested the hypothesis that CCL2 inhibition can enhance chemotherapy with carboplatin and paclitaxel. Elevated CCL2 expression was found in three non‐MDR paclitaxel resistant ovarian cancer lines ES‐2/TP, MES‐OV/TP and OVCAR‐3/TP, compared to parental cells. Mice xenografted with these cells were treated with the anti‐human CCL2 antibody CNTO 888 and the anti‐mouse MCP‐1 antibody C1142, with and without paclitaxel or carboplatin. Our results show an additive effect of CCL2 blockade on the efficacy of paclitaxel and carboplatin. This therapeutic effect was largely due to inhibition of mouse stromal CCL2. We show that inhibition of CCL2 can enhance paclitaxel and carboplatin therapy of ovarian cancer.  相似文献   
104.
105.
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-associated head and neck cancer that is most common in eastern Asia. Epstein-Barr virus infection, environmental factors, and genetic susceptibility play important roles in NPC pathogenesis. Jab1/CSN5 is a multifunctional protein that participates in affecting integrin signaling, controlling cell proliferation and apoptosis, and regulating genomic instability and DNA repair. Correlation of Jab1/CSN5 overexpression with poor prognosis for NPC provides evidence that it is involved in the tumorigenic process. In this review, we highlight recent advances in studies of the oncogenic role of Jab1/CSN5 in NPC and its potential as a therapeutic target for this cancer.  相似文献   
106.
107.
108.
109.
BackgroundReactive oxygen species (ROS) play a fundamental role in angiogenesis, and in turn, angiogenic growth factors also affect ROS. Angiogenesis and ROS are intricately involved in vascular deterioration. Since black populations are known to have elevated oxidative stress and hypertension, we determined whether relationships exist between angiogenic growth factors and serum peroxides in Africans and Caucasians and evaluated the relationships with cardiovascular measurements.MethodsWe measured vascular endothelial growth factor-A (VEGF), angiopoietin 2 (Ang-2), and serum peroxides in Africans (N = 262) and Caucasians (N = 364) aged 20 to 70 years.ResultsAfricans displayed higher blood pressure, serum peroxide levels, VEGF, and Ang-2 (all P ≤ .002) than similarly aged Caucasians (P = .44). In multivariable adjusted analyses, Ang-2 was independently associated with serum peroxides in African men (R2 = 0.31; β = 0.21; P = .014) and women (R2 = 0.09; β = 0.22; P = .025); and VEGF with serum peroxides in African men (R2 = 0.12; β = 0.24; P = .014), with no statistically significant associations in Caucasians. Cardiovascular measurements did not associate with serum peroxides or angiogenic factors in any subgroup.ConclusionsSignificant independent relationships exist between angiogenic growth factors and serum peroxides only in Africans who also displayed an unfavorable cardiovascular profile when compared with Caucasians. These results suggest that interplay between ROS and angiogenesis occur in African individuals that may form part of the mechanisms involved in vascular deterioration.  相似文献   
110.
Background: Hepatic arterial Doppler sonography is increasingly being used in liver diagnostics. The determinants of the elevation of hepatic artery impedance indexes in chronic liver disease, however, have still not been fully clarified. The aim of the present study was to investigate the relationship between histological alterations and liver circulation in chronic hepatitis. Methods: Hepatic artery resistance index and portal flow velocity were measured using Doppler sonography in 47 patients with chronic hepatitis of viral origin diagnosed at histopathology. The patients were divided into two groups, those with mild and those with severe alterations, in accordance with the various histological parameters of the Knodell scoring system. Results:  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号